ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2

ObjectivesEstrogen is proven to promote the malignant behaviors of many cancers via its receptors. Estrogen receptor alfa 36 (ER-α36) is a newly identified isoform of estrogen receptor alfa (ER-α), the role of ER-α36 in regulating the effects of estrogen and its potential impact on human cervical ca...

Full description

Bibliographic Details
Main Authors: Chunyan Wang, Tianli Zhang, Kun Wang, Shuo Zhang, Qing Sun, Xingsheng Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.712849/full
id doaj-1e3feba705d94477853a931b448a922c
record_format Article
spelling doaj-1e3feba705d94477853a931b448a922c2021-07-14T12:32:43ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-07-011110.3389/fonc.2021.712849712849ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2Chunyan Wang0Tianli Zhang1Kun Wang2Shuo Zhang3Qing Sun4Xingsheng Yang5Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaSchool of Medicine, Cheeloo College of Medicine, Shandong University, Jinan, ChinaDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, ChinaObjectivesEstrogen is proven to promote the malignant behaviors of many cancers via its receptors. Estrogen receptor alfa 36 (ER-α36) is a newly identified isoform of estrogen receptor alfa (ER-α), the role of ER-α36 in regulating the effects of estrogen and its potential impact on human cervical cancer is poorly understood.MethodsImmunohistochemistry staining was used to evaluate the expression of ER-α36, estrogen receptor alfa 66 (ER-α66) and their prognostic values in cervical cancer. The effects of ER-α36 and ER-α66 on the proliferation and metastasis of cervical cancer were measured in vitro. A xenograft tumor assay was used to study the tumorigenesis role of ER-α36 in vivo. Furthermore, the functional gene at the downstream of ER-α36 was obtained via next-generation sequencing, and the biological functions of high mobility group A2 (HMGA2) in cervical cancer cells were investigated in vitro.ResultsER-α36 was over-expressed in cervical cancer tissues and elevated ER-α36 expression was associated with poor prognosis in cervical cancer patients. High expression of ER-α36 promoted the proliferation, invasion and metastasis of cervical cancer cells mediated by estrogen, while silencing ER-α36 had the opposite effects. Further research showed that HMGA2 was a downstream target of ER-α36 in cervical cancer cells. The oncogenic effect of ER-α36 was attenuated after HMGA2 knockdown.ConclusionsHigh expression of ER-α36 was correlated with a poor prognosis in cervical cancer by regulating HMGA2. ER-α36 could be a prognostic biomarker and a target for cervical cancer treatment.https://www.frontiersin.org/articles/10.3389/fonc.2021.712849/fullcervical cancerER-α36HMGA2proliferationmetastasis
collection DOAJ
language English
format Article
sources DOAJ
author Chunyan Wang
Tianli Zhang
Kun Wang
Shuo Zhang
Qing Sun
Xingsheng Yang
spellingShingle Chunyan Wang
Tianli Zhang
Kun Wang
Shuo Zhang
Qing Sun
Xingsheng Yang
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
Frontiers in Oncology
cervical cancer
ER-α36
HMGA2
proliferation
metastasis
author_facet Chunyan Wang
Tianli Zhang
Kun Wang
Shuo Zhang
Qing Sun
Xingsheng Yang
author_sort Chunyan Wang
title ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
title_short ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
title_full ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
title_fullStr ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
title_full_unstemmed ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
title_sort er-α36 promotes the malignant progression of cervical cancer mediated by estrogen via hmga2
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-07-01
description ObjectivesEstrogen is proven to promote the malignant behaviors of many cancers via its receptors. Estrogen receptor alfa 36 (ER-α36) is a newly identified isoform of estrogen receptor alfa (ER-α), the role of ER-α36 in regulating the effects of estrogen and its potential impact on human cervical cancer is poorly understood.MethodsImmunohistochemistry staining was used to evaluate the expression of ER-α36, estrogen receptor alfa 66 (ER-α66) and their prognostic values in cervical cancer. The effects of ER-α36 and ER-α66 on the proliferation and metastasis of cervical cancer were measured in vitro. A xenograft tumor assay was used to study the tumorigenesis role of ER-α36 in vivo. Furthermore, the functional gene at the downstream of ER-α36 was obtained via next-generation sequencing, and the biological functions of high mobility group A2 (HMGA2) in cervical cancer cells were investigated in vitro.ResultsER-α36 was over-expressed in cervical cancer tissues and elevated ER-α36 expression was associated with poor prognosis in cervical cancer patients. High expression of ER-α36 promoted the proliferation, invasion and metastasis of cervical cancer cells mediated by estrogen, while silencing ER-α36 had the opposite effects. Further research showed that HMGA2 was a downstream target of ER-α36 in cervical cancer cells. The oncogenic effect of ER-α36 was attenuated after HMGA2 knockdown.ConclusionsHigh expression of ER-α36 was correlated with a poor prognosis in cervical cancer by regulating HMGA2. ER-α36 could be a prognostic biomarker and a target for cervical cancer treatment.
topic cervical cancer
ER-α36
HMGA2
proliferation
metastasis
url https://www.frontiersin.org/articles/10.3389/fonc.2021.712849/full
work_keys_str_mv AT chunyanwang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2
AT tianlizhang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2
AT kunwang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2
AT shuozhang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2
AT qingsun era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2
AT xingshengyang era36promotesthemalignantprogressionofcervicalcancermediatedbyestrogenviahmga2
_version_ 1721302892808241152